However, you can amend your search to find:
Lead oncology small molecule discovery programs from target identification and validation through PCC nomination. Integrate expertise across biology, medicinal chemistry, in vitro and in vivo pharmacology, DMPK, translational sciences, biomarkers,
You will lead TxM strategy and activities in the project Core Team and represent non-clinical DMPK strategy from late research onward—partnering across ADME/DMPK, non-clinical safety, quantitative pharmacology, formulation, and clinical pharmacology to
In this assignment the GPH will be accountable for the compound clinical development strategy and execution, with a focus on studies for regulatory purposes and including budget planning. The GPH will collaborate with the Principal Clinical Lead (PCL) and